XPA剪接变异导致着色性干皮病临床特征延迟出现
研究报道2例无关塞浦路斯XP-A患者,携带XPA基因纯合错义变异c.389G>A/p.R130K,临床表现轻微且发病延迟;分子分析显示该变异实际导致剪接缺陷、XPA mRNA减少、蛋白水平极低但残余NER活性,解释了轻表型。
要点
- XPA c.389G>A/p.R130K虽为错义变异,但实际通过剪接缺陷降低XPA mRNA和蛋白水平。
- 携带该变异的XP-A患者可表现为迟发型、轻度临床表型,甚至高龄仍无神经异常。
- 基因型-剪接-临床表型关系复杂,XP-A诊断需结合功能学与分子学分析。
核心结论
- XPA基因c.389G>A/p.R130K变异通过剪接缺陷导致XPA mRNA减少和蛋白水平极低,但保留残余NER活性,从而表现为迟发型轻度XP-A临床表型。
研究设计与样本
- 病例报告研究,描述2例无关塞浦路斯XP-A患者,并进行成纤维细胞分子与功能分析。
主要发现
- 69岁患者于40多岁时出现进行性神经退行性变,32岁患者迄今无神经异常。
- 患者成纤维细胞显示严重转录偶联NER缺陷和全局基因组NER降低,符合XP-A诊断。
- 尽管氨基酸替换保守,患者XPA蛋白水平极低;XPAR130K蛋白本身稳定且具NER功能,但XPAc.389G>A基因剪接缺陷导致XPA mRNA水平降低。
临床怎么用
- 对临床表现轻微或迟发的疑似XP-A患者,应警惕剪接变异可能,不能仅凭错义变异预测表型。
- XP-A诊断需结合NER功能学检测与XPA mRNA/蛋白水平分析。
局限性
- 仅基于2例无关患者的病例报告,样本量有限,结论普适性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by defective nucleotide excision repair (NER), leading to extreme sensitivity to sunlight-induced skin pigmentation changes and increased skin cancer risk. Patients with XP present with varying severity, often influenced by specific variants in NER-associated genes. In this study, we describe 2 unrelated Cypriot patients with XP-A with a mild phenotype linked to a homozygous missense variant in XPA (ENST00000375128.5:c.389G>A/ENSP00000364270.5:p.R130K, further referred to as XPAc.389G>A/XPAR130K). The older patient, aged 69 years, developed progressive neurological degeneration in his 40s, whereas the younger patient, aged 32 years, has no neurological abnormalities to date. Molecular analysis revealed a severe transcription-coupled NER defect and reduced global genome repair (global genome NER) in patient fibroblasts, consistent with the XP-A diagnosis. Surprisingly, very low XPA protein levels were detected, despite the conservative amino acid substitution. Further experiments demonstrated that although the XPAR130K protein variant is both stable and functional in NER, it is a splice defect in the XPAc.389G>A gene in patients that leads to reduced XPA mRNA levels, ultimately explaining the low protein levels and residual NER activity in patients. This study highlights the complex relationship between genotype, splicing, and clinical phenotype in patients with XP-A.
引用
- van den Heuvel A, Wondergem AP, Kim M, et al. A Splicing Variant in XPA Results in Delayed Onset of Clinical Features of Xeroderma Pigmentosum. J Invest Dermatol. 2025. PMID: 41005614. doi:10.1016/j.jid.2025.08.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。